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Abstract
Stem cell therapy has revolutionized modern clinical therapy with the potential of stem cells to differentiate into
many different cell types which may help to replace different cell lines of an organism. Innumerous trials are carried
out to merge new scientific knowledge and techniques with traditional herbal extracts that may result in less toxic,
affordable, and highly available natural alternative therapeutics. Currently, mesenchyamal stromal cell (MSC) lines
are treated with individual and mixtures of crude herbal extracts, as well as with purified compounds from herbal
extracts, to investigate the mechanisms and effects of these on stem cell growth and differentiation. Human MSCs
(hMSCs) possess multilineage, i.e., osteogenic, neurogenic, adipogenic, chondrogenic, and myogenic, differentiation
abilities. The proliferative and differentiation properties of hMSCs treated with herbal extracts have shown promise
in diseases such as osteoporosis, neurodegenerative disorders, and other tissue degenerative disorders. Well
characterized herbal extracts that result in increased rates of tissue regeneration may be used in both stem cell
therapy and tissue engineering for replacement therapy, where the use of scaffolds and vesicles with enhanced
attaching and proliferative properties could be highly advantageous in the latter. Although the clinical application
of herbal extracts is still in progress due to the variability and complexity of bioactive constituents, standardized
herbal preparations will strengthen their application in the clinical context. We have critically reviewed the proliferative
and differentiation effects of individual herbal extracts on hMSCs mainly derived from bone marrow and elaborated
on the plausible underlying mechanisms of action. To be fruitfully used in reparative and regenerative therapy,
future directions in this area of study should (i) make use of hMSCs derived from different non-traditional sources,
including medical waste material (umbilical cord, Wharton’s jelly, and placenta), (ii) take account of the vast numbers of
herbal extracts used in traditional medicine globally, and (iii) investigate the mechanisms and pathways of their effects
on hMSCs.
Keywords: Stem cell therapy, Human mesenchymal stromal cells, Bone marrow derived, Proliferation and differentiation
effectors, Synthetic stimuli, Herbal extracts, Standardization and quality control, Reparative and regenerative therapy
Background
Stem cell therapy is at the forefront of regenerative
medicine with the goal of regenerating and repairing in-
jured tissues in the body. It is emerging as a promising
therapeutic technique where tissues generated from
stem cells are grafted on damaged tissue to repair and
regenerate the original tissue [1]. In addition, stem cells
are being investigated for their potential to produce
whole organs for organ replacement. This rapidly evolv-
ing field of therapy has great promise in treating incur-
able diseases such as Parkinson’s disease [2], Alzheimer’s
disease [3], and diabetes mellitus [4].
Stem cells possess the ability to self-renew and to dif-
ferentiate into a plethora of different mature cell lineages
under certain physiological or experimental conditions.
Human mesenchymal stromal cells (hMSCs) are a multi-
potent group of cells that can be effortlessly isolated
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from a number of adult tissue types such as bone mar-
row, adipose tissue, and medical waste material such as
umbilical cord and placenta [5]. These have the potential
to differentiate into a wide variety of cell lineages (i.e.,
osteoblasts, adipocytes, chondrocytes, tenocytes, and
myocytes [5]) with much promise for use in stem cell
therapy. Due to these advantageous properties of MSCs,
techniques for increasing MSC proliferation and differ-
entiation are under much scrutiny. In existing stem cell
therapy, extensive use of synthetic and semi-synthetic
substances, i.e., recombinant cytokines and growth fac-
tors currently used as proliferative and differentiation
factors in stem cell therapy, may lead to side effects and
toxicity while being exorbitantly expensive. Due to these
drawbacks, researchers are constantly searching for al-
ternative natural products to be used as growth factors
in stem cell therapy.
Herbal remedies have been used in traditional medicine
practices for centuries for a wide range of diseases and are
a promising alternative, offering substantial improvement
of patient conditions and significantly decreased disease
symptoms [6, 7], although the mechanisms of action of in-
dividual and mixtures of herbal plant extracts mostly re-
main undetermined. Investigating the proliferative,
differentiation, and cytotoxic effects of different herbal ex-
tracts on stem cells may provide in-depth insights into
their disease-curing mechanisms.
Low rejection rates, the availability and easy isolation
of source cells, and in vitro culturing methods have
made stem cell therapy advantageous over many other
therapeutic methods. New technologies in the emerging
field of regenerative medicine and stem cell therapy are
currently under development. In the US, more than 100
companies invested nearly 850 million dollars in 2007
and over 55 products were in either clinical or preclin-
ical trials [8]. The literature reviewed here is on recent
investigations on the effects of different individual and
mixtures of herbal extracts on the proliferation and dif-
ferentiation of hMSCs, with their underlying mecha-
nisms of action elucidated where possible (summarized
in Fig. 1).
Mesenchymal stromal cells
Because of their scientifically proven abilities and enormous
clinical potential, MSCs are currently being researched ex-
tensively worldwide.
MSCs are a type of multipotent stem cell and are cate-
gorized as adult stem cells as they are isolated from
adult tissues. They have the potential to differentiate
naturally into adipocytes, osteocytes, and chondrocytes
and can be induced into muscle, neurons, glia, and
tendon-ligament [9]. MSCs reside in almost all postnatal
human tissues and can be easily isolated from bone mar-
row (BM), umbilical cord (UC), umbilical cord blood
(UCB), adipose tissue, dental pulp, cervical tissue, and
muscle tissue [10]. MSCs have advantages over embry-
onic stem cells (ESCs), such as their easy isolation and
in vitro culture and minimal ethical issues associated
with their use, and, because of their HLA-DR (human
leukocyte antigen-antigen D related)-negative character-
istic, they are not recognized as foreign cells when used
in therapy [9].
The in vitro culture and differentiation of hMSCs de-
rived from BM was practiced in laboratories globally
until recent years but sampling difficulties and age-
dependent decreases in the number and differentiation
Fig. 1 Human mesenchymal stromal cells (hMSCs) are isolated from different tissue types and can be proliferated and differentiated using both
synthetic and herbal extracts into different cell types. Both synthetic and herbal effectors have their advantages and disadvantages in hMSC
proliferation and differentiation
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potential of hMSCs led to the search for alternative
sources [11]. UC and UCB are disposable biological ma-
terial/medical waste at parturition and have been used in
scientifically proven procedures to isolate hMSCs with
the potential to differentiate into multipotent cell types
[12, 13]. Due to the high availability of UC and UCB,
hMSC requirements for transplantation could be ful-
filled easily using them [14]. Extra-embryonic tissue-
derived MSCs have demonstrated immune-privileged
characteristics and broader multipotent plasticity [15].
UCB-hMSCs have demonstrated the highest rates of cell
proliferation and clonality and significantly lower expres-
sion of p53, p21, and p16, well known markers of senes-
cence, compared with BM-hMSCs and adipose tissue-
derived (AD) hMSCs [16]. This has made UC- and
UCB-derived hMSCs more popular than those derived
from BM in recent years.
In 2015, 493 MSC-based clinical trials were recorded
in the database of the US National Institutes of Health,
those on bone and cartilage diseases being the highest
proportion and cardiovascular diseases being the second
highest [10]. hMSCs are currently used in clinical studies
of tissue engineering [17], clinical engraftments to repair
damaged tissues, and immune disorder therapy [18].
They also have potential applications in dentistry, meta-
bolic disorders, disorders that result in tissue degener-
ation, and replacing damaged tissue due to accidents.
Clinical trials for osteoporosis are being carried out
using hMSCs derived from different sources such as
BM, adipose tissue, and UC tissue by exogenous intro-
duction of the stem cells into osteoporosis sites [19]. Re-
search on diabetes have utilized MSCs to produce
insulin-producing cells [20], treat diabetic ulcers and
limb ischemia [21], and enhance islet engraftment and
survival [22]. The potential of MSCs to regenerate heart
and skeletal muscle tissue has been investigated in mur-
ine models, with results leading to preclinical trials on
Duchenne muscular dystrophy to replace degenerating
muscle tissue and also as carriers with a functioning dys-
trophin gene [23]. MSCs are candidates in cancer ther-
apy as carriers for anticancer gene therapy [24] and have
proven their ability as anti-tumor agents against Kaposi’s
sarcoma [25], colon carcinoma [26], Lewis Lung carcin-
oma, and B16F10 melanoma [27].
Current stimulants in stem cell therapy: cytokines
and growth factors
Different semi-biological and synthetic substances are
currently used for the proliferation and differentiation of
MSCs. During the early scientific research, components
isolated from human biological sources were used for
this [28] but because of ethical controversies and the
long and tedious downstream processing for the isola-
tion and purification of such substances, recombinant
and synthetic components have emerged as replace-
ments. Currently, a cocktail of dexamethasone, ascorbic
acid, and β-glycerophosphate is used for in vitro osteo-
genic differentiation of hMSCs, while 3-isobutyl-1-meth-
ylxanthine, hydrocortisone, and indomethacin are used
for adipogenic differentiation, and fibroblast growth fac-
tor and bone morphogenetic protein (BMP)-2 are used
for higher rates of proliferation [12, 29]. Several extracel-
lular matrix proteins have demonstrated proliferation
and differentiation potential-preserving properties [29].
A cytokine, granulocyte colony stimulating factor (G-
CSF), has been used to mobilize and differentiate murine
MSCs into cardiomyocytes [30].
Drawbacks of current stimulants
Many companies produce recombinant cytokines using
Escherichia coli cells, plant cells, and other mammalian
cells. Yet, the recombinant and synthetic cytokines,
growth factors, and other proteins involved in the prolif-
eration and differentiation of stem cells used in cell cul-
ture and in clinical treatment may show side effects and
toxic effects [31] when used continuously and the stem
cells may have the potential for rejection due to the dif-
ferent origins of the stimulants. Ascorbic acid used for
osteogenic differentiation is unstable at 37 °C and toxic
at high doses [32]. Dexamethasone shows immunosup-
pressive properties, which limit its application in osteo-
blast differentiation [33], and some growth factors can
cause malignant formation in cells [34]. Most import-
antly, these reagents rapidly degrade and thus need to be
continuously replaced and are highly expensive, making
them unaffordable in developing countries. Due to these
restrictions, a new research stream has evolved to inves-
tigate the use of natural products as effective stem cell
proliferation and differentiation stimulants with mini-
mum side effects, low toxicity, and high availability and
affordability.
Herbal remedies
Herbal extracts have shown much promise in the prolif-
eration and differentiation of hMSCs in many different
studies. The origin of these herbal extracts is mainly
from Chinese traditional medicine, Indian Ayurveda
medicine, and other South East Asian and Middle East-
ern traditional medicine practices. Herbal extracts con-
tain a plethora of phytochemicals such as polyphenols,
flavonoids, and other plant-derived chemicals which syn-
ergistically aid in treating diseases in traditional medi-
cine methods. Not only individual herbal extracts but
also mixtures of different herbal extracts have shown
promising results in traditional medicine. Also, the dif-
ferent parts of medicinal herbs, such as roots, leaves,
stem, and fruits, are used in preparations for the treat-
ment of different diseases. The herb Tithonia diversifolia
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is a worthy example, an extract of it being used for the
treatment of diabetes, diarrhea, menstrual pain, malaria,
hematomas, hepatitis, hepatomas, and wound healing
[35]. The proven ability of many herbal extracts to treat
a range of diseases has captured the attention of modern
scientists and preliminary research is being carried out
using stem cells and other cell types to find herbal ex-
tracts that are suitable stimulants based on their promis-
ing results in traditional medicine. Since herbs grow
naturally, their local availability is high and the prelimin-
ary production costs will presumably be lower than for
recombinant growth factors. As these extracts are com-
posed of naturally occurring medicinal herbs, which may
be regularly consumed by local communities, these may
cause minimum side effects and have lower toxicity than
the current stimulants. Therefore, herbal remedies may
be safe and affordable alternatives to highly expensive
recombinant and synthetic stimulants.
Effects of herbal extracts on the differentiation and
proliferation of hMSCs
The studies described in the following sections elaborate
on such herbal remedies and their possible mechanisms
of action on hMSCs.
Osteogenic effects of herbal extracts
A traditional Chinese herbal formula (ZD-1) was found to
have stimulatory effects on the proliferation and inhibitory
effects on mineralization of hMSCs through down-
regulation of several osteogenic markers such as osteocal-
cin, BMP-2, and osteopontin in the late stages [36].
The dried root of Drynariae fortune, Rhizoma Drynar-
iae, contains flavonoid and triterpenoid compounds and
its use results in increased bone cell viability, intracellular
total proteins, alkaline phosphatase, and acid phosphatase
[37]. Naringin, which is the main component of the Rhi-
zoma Drynariae extract, enhanced the proliferation and
osteogenic differentiation of BM-derived hMSCs [38]. The
regulation of β-catenin, which is involved in osteoblasto-
genesis via Akt (protein kinase B) and AMPK (AMP acti-
vated protein kinase) signaling, has been demonstrated as
a possible mechanism for the osteogenic properties of nar-
ingin [39].
An ethanol extract of the fruit of Ligustrum lucidum
demonstrated an inhibitory activity on the proliferation
of BM-derived hMSCs in a dose-dependent manner and
a cytotoxic effect at a concentration of ≥200 μg/mL [40].
Conversely, the same study illustrated accelerated osteo-
genic activity at two specific concentrations, 50 μg/mL
and 75 μg/ml. A suggested mechanism of action is based
on a significant increase in expression of osteogenesis
stimulating genes, β-catenin, BMP-2, cyclin D1, MT1-
MMP (membrane type-1 matrix metalloproteinase), os-
teoprotegerin, and TBX3(T-Box 3) [40].
Dried root extract of the Korean herb Dipsacus asper,
Dipsaci Radix, is used in the treatment of bone fracture.
A dichloromethane fraction of Dipsaci Radix demon-
strated not only that the whole extract possessed the
ability to enhance osteoblastic differentiation from BM-
derived hMSCs, but that the isolated single compound
(hedraganin-3-O-(2-O-acetyl)-α-L-arabinopyranoside)
worked similarly. Researchers suggested that the en-
hanced osteoblast differentiation was due to induced
alkaline phophatase activity and expression of bone-
specific proteins (bone sialoprotein and osteocalcin) by
both the crude Dipsaci Radix extract and the isolated
compound [33].
Foeniculum vulgare has been used in traditional medi-
cine to increase milk secretion, promote menstruation,
facilitate birth, and alleviate the symptoms of dysmenor-
rhea, which are conditions involving estrogenic activity.
Based on estrogenic activity, a study on an ethanol extract
of F. vulgare dried root showed a significant increase of
BM-derived hMSC proliferation and differentiation into
osteoblasts. The antiosteoporotic activity was thought to
be stimulated through estrogenic activity of trans-anatole,
an abundant component of the F. vulgare extract [41].
Herba epimedii extract showed increased rates of
osteogenic activity on human BM-derived hMSCs via
enhanced mRNA expression of BMP-2, BMP-4, Runx2
(Runt-related transcription factor 2), beta-catenin, and
cyclinD1, all of which are BMP or Wnt signaling
pathway-related regulators. This elucidated that the fla-
vonoids of this extract promote osteogenesis through
the BMP or Wnt-signaling pathway [42].
Ferula gummosa is used in Iranian traditional medi-
cine and has applications in treating different types of
diseases. The ethanol root extract of F. gummosa was
proven to proliferate and differentiate human BM-
derived hMSCs into osteocytes, demonstrating increased
alkaline phosphatase activity [43].
Anti-adipogenic effects of herbal extracts
A Chinese herbal remedy, Quzhisu, had inhibitory ef-
fects on the adipogenic differentiation of BM-derived
hMSCs by reducing the expression of PPARγ (peroxi-
some proliferator activated receptor γ) mRNA [44].
Tithonia diversifolia demonstrated antioxidant proper-
ties, which may help in treating obesity, a condition as-
sociated with decreased antioxidant levels resulting in
high levels of adipogenesis [35]. This study recorded sig-
nificant antiadipogenic activity due to reduced levels of
reactive oxygen species by treating adipose derived
hMSCs with a T. diversifolia aqueous extract [35]. In-
creased levels of pAMPK (phosporylated 5′-adenosine
monophoshate-activated protein kinase), a key regulat-
ing enzyme involved in adipocyte differentiation and
maturation [45], were detected [35].
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Aloe-emodin is an anthraquinone present in aloe latex
and has proven inhibitory effects on adipocyte differenti-
ation when hMSCs were induced with 3-isobutyl-1-meth-
ylxanthine (IBMX) for adipogenesis. In comparison with
control cultures, hMSCs treated with aloe-emodin had re-
duced expression levels of mRNA for resistin, adiponectin,
aP(2), lipoprotein lipase, PPARγ, and tumor necrosis
factor-α, which influence adipogenic pathways [46].
Neurogenic effects of herbal extracts
BM-derived hMSCs treated with a 1 % acetic acid extract
of Mucuna gigantea had high proliferative characteristics
and exhibited higher expression of mRNA for nestin (a
neural precursor marker) and β-III tubulin (an immature
neuron marker), suggesting the importance of M. gigantea
in neural differentiation. As the M. gigantea extract con-
tains L-DOPA, which is a precursor for neurotransmitter
dopamine, using it in nerve-related stem cell therapy
would enhance treatment capacity [47].
The extract of Angelica sinensis (Danggui) dried root,
known as Radix Angelica sinesis (RAS), decreased β-
amyloid peptide-induced neurotoxicity and tau phos-
phorylation in cultured cortical neurons [48], suggesting
it has applications in neurodegenerative disorders. Treat-
ment with RAS extract showed significantly higher
percentages of neural like cell differentiation from AD-
hMSCs compared with hMSCs treated with butylated
hydroxyanisole; a commonly used neuronal inducer [49].
Ferulic acid, a main component of the RAS extract, also
has proven ability to inhibit neurotoxic β-amyloid pep-
tide aggregation in animal models [50], but the effects
on patients with neurodegenerative disorders are yet to
be determined.
Salvia miltiorrhiza extract demonstrated positive ef-
fects on differentiating Wharton jelly-derived hMSCs into
neural like cells with significant morphological changes.
Strongly positive markers were observed for nestin, β-
tubulin, neurofilament, and glial fibrillary acidic protein.
Neurite outgrowth-promoting protein expression (a
neural cell marker) was markedly increased in hMScs after
induction with the S. miltiorrhiza extract [51].
Endothelial/vascular genesis and angiogenesis effects of
herbal extracts
Olive leaf extract resulted in hMSCs differentiating into
endothelial cells and further into tubular structures, which
are required in angiogenesis and vasculogenesis processes,
while the genes for vascular endothelial growth factor,
PCAM, platelet derived growth factor receptor, and vascu-
lar endothelial growth factor receptor (VEGFR)-1, in-
volved in endothelial differentiation, are increasingly
expressed in olive leaf extract-treated cells [52].
The rhizome extract of Curcumin longa L contains the
phytochemical curcumin as the main component, which
has antioxidant and anti-inflammatory properties. As
stem cells require an antioxidant mechanism to survive
and repair cells, curcumin with its antioxidant properties
becomes a potential candidate to be applied in stem cell
therapy research. An ethanol extraction of curcumin
dried rhizome resulted in enhanced proliferation and
differentiation of AD-hMSCs into endothelial progenitor
cells through increased expression of the cell surface
markers CD34, CD133, and VEGFR2 [53].
Proliferative and other effects of herbal extracts
Dhanwantram kashaya, used in Ayurvedic medicine to
stimulate growth and nerve regeneration, resulted in in-
creased proliferation and delayed senescence of Wharton
jelly-derived hMSCs [54]. Yet another Chinese herbal
remedy, Dan-Qi-TongMai-Pian, prepared mainly using
Astragalus and Salvia, resulted in negative apoptosis of
BM-derived hMSCs via stimulating c-IAP-1/2 expression
and restricting caspase-3 activation [55].
The leaf extract of Carica papaya was found to have
an effect on improving thrombocyte counts in both hu-
man and murine models, which suggest C. papaya leaf
extract as an invaluable potential therapeutic agent for
diseases such as dengue. The C. papaya extract up-
regulated the in vitro synthesis of thrombopoiesis-
related cytokines interleukin-6 and stem cell factor by
hMSCs isolated from exfoliated deciduous teeth [56].
Viscum album, also known as Korean mistletoe lectin,
was investigated for cytotoxic and proliferative activities
on placenta-derived hMSCs. V. album extract showed
cytotoxicity on HepG2 cancer cells at low concentra-
tions of 1–5 pg/ml but induced significant proliferative
properties in naive placenta-derived hMSCs via autoph-
agy mechanisms [57].
Beneficial effects of herbal extracts in scaffolds
In vivo studies have shown an extract of Cissus quadran-
gularis, known as the Asthisandhani (bone setter) in In-
dian traditional medicine, to have bone fracture-healing
properties [58]. Scaffolds treated with a C. quadrangu-
laris extract showed significant differences with regard
to hMSC proliferation, attachment, and enhanced osteo-
blast differentiation properties compared with scaffolds
not treated with the extract [59].
The extract of Terminalia bellirica contains gallic acid,
with anti-oxidant and cytoprotective properties, as a
major component. In a study on hydrogel composition
for use in stem cell therapy, a T. bellirica extract was
found to result in significantly higher rates of hMSC
proliferation and cell attachment [60].
Adverse effects of herbal extracts
The root extract of Angelicae dahuricae has been used
as an anti-inflammatory, analgesic, antipyretic, and
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antioxidant remedy in Chinese and Korean herbal medi-
cine. Nevertheless, this did not produce any significant
rates of proliferation in hMSCs derived from gingiva [61].
The dried root of Cimicifuga heracleifolia or Cimicifuga
foetida is known as Cimicifugae Rhizoma. An extract of
Cimicifugae Rhizoma possesses anti-inflammatory, anal-
gesic, and antipyretic properties and also been suggested
as a potential treatment for dental diseases. hMSCs de-
rived from healthy gingival tissue were treated with an
aqueous Cimicifugae Rhizoma extract which, at high con-
centrations (such as 100 and 1000 μg/ml) affected stem
cell morphology and reduced cell viability, suggesting po-
tential adverse effects if administered orally [62].
A study on a root extract of Asiasarum, suggested for
treating oral diseases, showed reduced cell viability of
hMSCs derived from gingiva at higher concentrations
(such as 100 and 1000 μg/ml), suggesting adverse effects
on oral tissues at high doses of the extract [63].
Current drawbacks of use of herbal extracts
Herbal extracts may show promising results in in vitro
studies but to apply these natural products in stem cell
therapy will require more quality research to provide a
better understanding into their mechanisms of action
and effective pathways. As a crude extract a herbal could
display beneficial properties, but its efficacy may be re-
duced during the manufacturing processes when pro-
duced at a commercial scale. Also, different solvents
used to prepare crude extracts may cause adverse effects
when used in therapy. Decreased absorption problems
may occur when administered orally or intravenously;
hence, local administration would be required when
transplantation is performed, which can result in an in-
vasive, painful procedure for the patient.
Although herbal products are endorsed as an excellent
alternative to synthetic interventions, clinical applications
are challenging due to the variability and complexity of
bioactive constituents present in herbal formulations.
Genetic, environmental, and cultural factors as well as the
process of preparation affect the quality and the quantity
of bioactive constituents, which may lead to undesirable
side effects and low bioactivities. A well-defined and con-
stant composition of the active constituents is a prerequis-
ite for clinical application. Hence, “standardization”, which
entails a set of scientific evaluations that assure quality, ef-
ficacy, safety, and reproducibility, was introduced to en-
sure the safety of herbal formulations in the global market
[64]. Proper standardization will minimize quality issues
with herbal preparations and ensure safe application of
these in stem cell therapy.
Conclusion
Stem cell therapy has immense potential in clinical use
when linked with the differentiation and proliferative
properties of herbal extracts. Cutting edge technology
and widening knowledge in medicine have led re-
searchers to investigate the pathways and regulatory ef-
fects of herbal extracts on stem cells, which have shown
positive effects in a wide range of diseases.
According to the literature reviewed, herbal extracts as
stimulants of hMSC proliferation and differentiation
show outstanding results and are suitable for further in-
vestigations on their chondrogenic, osteogenic, vasculo-
genic, and neurogenic potential. The proliferative and
differentiation activities of hMSCs treated with herbal
extracts may provide for future therapeutics and tissue
replacements for diseases such as osteoporosis, heart
disease, Parkinson’s disease, and cartilage replacement.
Herbal extracts may also be used to treat attaching gels
and scaffolds in regenerative therapy. Nevertheless better
insights into their mechanisms and modes of action
should be studied using hMSCs as most studies have so
far been restricted to in vitro and in vivo studies of mur-
ine models.
Most of the studies reviewed here were aimed at
osteogenic differentiation and proliferation of BM-
derived hMSCs; the reason for the extensive use of BM-
derived hMSCs in research is their well characterized
nature and the wide experience with these cell lines.
Nonetheless, studies on hMScs derived from non-
traditional sources, such as AD-hMSCs and those from
medical waste at parturition, such as UC-, UCB-, and
Wharton jelly-derived hMSCs, and placental hMSCs, are
being explored since these are associated with fewer eth-
ical considerations than other stem cells and they can be
obtained using easy sampling methods. Use of embryos
for ESC culture is bound by heavy ethical regulations
and religious issues globally. hMSCs are mainly isolated
from surgical and parturition waste material, so use of
these biological sources does not concern donors to a
greater extent, whereas donors are highly concerned
about the use of embryos in ESC procedures.
As most of the discussed stimulants are crude extracts
of medicinal herbs, once standardized, producing these
at a commercial scale will be highly cost effective com-
pared with a recombinant, synthetic line of stimulants.
Also, production lines could be established globally, with
medicinal herbs grown locally in different regions. Once
their availability becomes high and costs decrease, stem
cell therapy research and clinical applications will be af-
fordable worldwide, which would help to increase
disease-treating capabilities using stem cell therapy.
Legal complications may arise due to the use of indigen-
ous herbal varieties in foreign production lines, but a
globally accepted agreement may successfully address
this issue. Several herbal medicines, including Curcuma
longa and Salvia, discussed in this review have beneficial
immunomodulatory properties which would boost the
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use of certain herbals in clinical applications [65]. This
review aims to direct stem cell researchers to a poten-
tially effective novel world of stimulants which is cur-
rently in its infancy but may pave the way as invaluable
candidates in future regenerative and reparative clinical
applications with further research.
Strategic use of herbal remedies as stimulants of prolif-
eration and differentiation in stem cell therapy may result
in cost-effective, highly available, non-toxic alternatives for
therapeutic application as there are vast number of herbal
extracts used in traditional medicine globally. Well stan-
dardized herbal preparations with consistent quality and
effects will be a potential breakthrough in stem cell
therapy.
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